The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Pathophysiology of muscle dysfunction in COPD
Open accessAbstract
Muscle dysfunction often occurs in patients with chronic obstructive pulmonary disease (COPD) and may involve both respiratory and locomotor (peripheral) muscles. The loss of strength and/or endurance in the former can lead to ventilatory insufficiency, whereas in the latter it limits exercise capacity and activities of daily life. Muscle dysfunction is the consequence of complex interactions between local and systemic factors, frequently coexisting in COPD patients. Pulmonary hyperinflation along with the increase in work of breathing that occur in COPD appear as the main contributing factors to respiratory muscle dysfunction. By contrast, deconditioning seems to play a key role in peripheral muscle dysfunction. However, additional systemic factors, including tobacco smoking, systemic inflammation, exercise, exacerbations, nutritional and gas exchange abnormalities, anabolic insufficiency, comorbidities and drugs, can also influence the function of both respiratory and peripheral muscles, by inducing modifications in their local microenvironment. Under all these circumstances, protein metabolism imbalance, oxidative stress, inflammatory events, as well as muscle injury may occur, determining the final structure and modulating the function of different muscle groups. Respiratory muscles show signs of injury as well as an increase in several elements involved in aerobic metabolism (proportion of type I fibers, capillary density, and aerobic enzyme activity) whereas limb muscles exhibit a loss of the same elements, injury, and a reduction in fiber size. In the present review we examine the current state of the art of the pathophysiology of muscle dysfunction in COPD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of ubiquitin ligases required for skeletal muscle atrophy.
Bodine, S. C., Latres, E., Baumhueter, S., Lai, V. K.-M., Nunez, L., Clarke, B. A., Poueymirou, W. T., Panaro, F. J., Na, E., Dharmarajan, K., et al. (2001) · Science · doi:10.1126/science.1065874 · Cited by 3,521 · cited 1×
“The proteasome is a cellular structure that degrades proteins (mostly those previously tagged with ubiquitins through different ligases) and peptides (especially those which have been modified by oxidative stress) (18, 133, 162, 173, 186, 197) (Fig.”
Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S. H., & Goldberg, A. L. (2004) · Cell · doi:10.1016/s0092-8674(04)00400-3 · Cited by 3,012
Skeletal muscle hypertrophy and atrophy signaling pathways
Glass, D. J. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.04.018 · Cited by 1,106 · cited 1×
“This is the case of apoptosis, autophagy, oxidative stress, and catabolic systems such as that of the ubiquitin proteasome (62).”
Peripheral Muscle Weakness in Patients with Chronic Obstructive Pulmonary Disease
BERNARD, S., LeBLANC, P., WHITTOM, F., CARRIER, G., JOBIN, J., BELLEAU, R., & MALTAIS, F. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.2.9711023 · Cited by 817
Swallow, E. B., Reyes, D., Hopkinson, N. S., Man, W. D.-C., Porcher, R., Cetti, E. J., Moore, A. J., Moxham, J., & Polkey, M. I. (2007) · Thorax · doi:10.1136/thx.2006.062026 · Cited by 728
Contractile Properties of the Human Diaphragm during Chronic Hyperinflation
Similowski, T., Yan, S., Gauthier, A. P., Macklem, P. T., & Bellemare, F. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109263251304 · Cited by 473
Brodsky, I. G., Balagopal, P., & Nair, K. S. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.10.8855787 · Cited by 444 · cited 1×
“Testosterone increases the synthesis of muscle structural proteins, an action that can lead to muscle hypertrophy (21).”
Changes in musculoskeletal structure and function with prolonged bed rest
BLOOMFIELD, S. A. (1997) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-199702000-00006 · Cited by 443
Skeletal Muscle Apoptosis and Weight Loss in Chronic Obstructive Pulmonary Disease
Agustí, A. G. N., Sauleda, J., Miralles, C., Gomez, C., Togores, B., Sala, E., Batle, S., & Busquets, X. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2108013 · Cited by 343
Self-citationAn overview of the issues: physiological effects of bed rest and restricted physical activity
CONVERTINO, V. A., BLOOMFIELD, S. A., & GREENLEAF, J. E. (1997) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-199702000-00004 · Cited by 309 · cited 1×
“Second, many of the changes and phenomena reported in peripheral muscles of COPD patients (this will be reviewed in more detail in other reviews of the present highlighted topic) are quite similar to those described in muscle disuse (17, 26, 27).”
Barreiro, E., Peinado, V. I., Galdiz, J. B., Ferrer, E., Marin-Corral, J., Sánchez, F., Gea, J., & Barberà, J. A. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200908-1220oc · Cited by 272 · cited 4×
“However, the absence of correlations between the level of inflammatory markers in the lung and blood or other organs including muscles, and the presence of muscle changes preceding pulmonary abnormalities strongly argue against this possibility (13, 66, 183).”
InfluentialSelf-citationMuscle Atrophy and Hypertrophy Signaling in Patients with Chronic Obstructive Pulmonary Disease
Doucet, M., Russell, A. P., Léger, B., Debigaré, R., Joanisse, D. R., Caron, M.-A., LeBlanc, P., & Maltais, F. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200605-704oc · Cited by 243 · cited 1×
“In COPD, this occurs mostly through activation of the ubiquitin-proteasome system (34, 46, 55, 143).”
Chronic Obstructive Pulmonary Disease: Capillarity and Fiber-Type Characteristics of Skeletal Muscle
Jobin, J., Maltais, F., Doyon, J.-F., LeBlanc, P., Simard, P.-M., Simard, A.-A., & Simard, C. (1998) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-199811000-00005 · Cited by 224
Gosker, H. R., Engelen, M. P., van Mameren, H., van Dijk, P. J., van der Vusse, G. J., Wouters, E. F., & Schols, A. M. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.1.113 · Cited by 200
Cellular Markers of Muscle Atrophy in Chronic Obstructive Pulmonary Disease
Plant, P. J., Brooks, D., Faughnan, M., Bayley, T., Bain, J., Singer, L., Correa, J., Pearce, D., Binnie, M., & Batt, J. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0382oc · Cited by 190
O'Shea, S. D., Taylor, N. F., & Paratz, J. D. (2009) · Chest · doi:10.1378/chest.09-0029 · Cited by 163
Downregulation of the Serum Response Factor/MiR-1 Axis in the Quadriceps of Patients with COPD
Lewis, A., Riddoch-Contreras, J., Natanek, S. A., Donaldson, A., Man, W. D.-C., Moxham, J., Hopkinson, N. S., Polkey, M. I., & Kemp, P. R. (2012) · Thorax · doi:10.1136/thoraxjnl-2011-200309 · Cited by 156
SAULEDA, J., GARCÍA-PALMER, F., WIESNER, R. J., TARRAGA, S., HARTING, I., TOMÁS, P., GÓMEZ, C., SAUS, C., PALOU, A., & AGUSTÍ, A. G. N. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.5.9710039 · Cited by 154
Self-citationDoes Oxidative Stress Modulate Limb Muscle Atrophy in Severe COPD Patients?
Fermoselle, C., Rabinovich, R., Ausín, P., Puig-Vilanova, E., Coronell, C., Sanchez, F., Roca, J., Gea, J., & Barreiro, E. (2012) · European Respiratory Journal · doi:10.1183/09031936.00137211 · Cited by 148
Self-citationMuscle Wasting and Changes in Muscle Protein Metabolism in Chronic Obstructive Pulmonary Disease
Jagoe, R. T., & Engelen, M. P. K. J. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00004608 · Cited by 134
Skeletal Muscle Inflammation and Nitric Oxide in Patients with COPD
Montes de Oca, M., Torres, S. H., De Sanctis, J., Mata, A., Hernández, N., & Tálamo, C. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00107404 · Cited by 123
Engelen, M. P., Wouters, E. F., Deutz, N. E., Menheere, P. P., & Schols, A. M. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.6.1480 · Cited by 116 · cited 1×
“Moreover, malnourishment often associates with muscle weakness (5, 201) and poor prognosis (202, 211), which is believed to be the result of the interaction between different factors, including reduced energy intake, systemic inflammation, enhanced lipolysis and, of particular interest, a mismatching between muscle pr…”
POUW, E. M., SCHOLS, A. M. W. J., DEUTZ, N. E. P., & WOUTERS, E. F. M. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.3.9708097 · Cited by 114
Muscle and Blood Redox Status after Exercise Training in Severe COPD Patients
Rodriguez, D. A., Kalko, S., Puig-Vilanova, E., Perez-Olabarría, M., Falciani, F., Gea, J., Cascante, M., Barreiro, E., & Roca, J. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.09.022 · Cited by 102
Self-citationNutritional Aspects of Chronic Obstructive Pulmonary Disease
King, D. A., Cordova, F., & Scharf, S. M. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200707-092et · Cited by 92
Ribera, F., N'Guessan, B., Zoll, J., Fortin, D., Serrurier, B., Mettauer, B., Bigard, X., Ventura-Clapier, R., & Lampert, E. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200206-519oc · Cited by 91
Inflammatory Cells and Apoptosis in Respiratory and Limb Muscles of Patients with COPD
Barreiro, E., Ferrer, D., Sanchez, F., Minguella, J., Marin-Corral, J., Martinez-Llorens, J., Lloreta, J., & Gea, J. (2011) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01017.2010 · Cited by 79
Self-citationGene Expression Profiling in Vastus Lateralis Muscle During an Acute Exacerbation of COPD
Crul, T., Testelmans, D., Spruit, M., Troosters, T., Gosselink, R., Geeraerts, I., Decramer, M., & Gayan-Ramirez, G. (2010) · Cellular Physiology and Biochemistry · doi:10.1159/000303054 · Cited by 79
Role of Autophagy in COPD Skeletal Muscle Dysfunction
Hussain, S. N. A., & Sandri, M. (2013) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00893.2012 · Cited by 77
Turan, N., Kalko, S., Stincone, A., Clarke, K., Sabah, A., Howlett, K., Curnow, S. J., Rodriguez, D. A., Cascante, M., O'Neill, L., et al. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002129 · Cited by 74
Self-citationRespiratory and Skeletal Muscles in Hypogonadal Men with Chronic Obstructive Pulmonary Disease
Laghi, F., Langbein, W. E., Antonescu-Turcu, A., Jubran, A., Bammert, C., & Tobin, M. J. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200412-1643oc · Cited by 57 · cited 2×
“However, the implications of this hypogonadism on muscle dysfunction are not clear, since either muscle strength and endurance or exercise capacity appears to remain unaltered (100).”
Puente-Maestu, L., Tejedor, A., Lázaro, A., de Miguel, J., ÁLvarez-Sala, L., González-Aragoneses, F., Simón, C., & Agustí, A. (2012) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2011-0382oc · Cited by 51
Self-citation
Cited by
Köhnlein, T., Windisch, W., Köhler, D., Drabik, A., Geiseler, J., Hartl, S., Karg, O., Laier-Groeneveld, G., Nava, S., Schönhofer, B., et al. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70153-5 · Cited by 815
Early chronic obstructive pulmonary disease: definition, assessment, and prevention
Rennard, S. I., & Drummond, M. B. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60647-x · Cited by 265
Barreiro, E., & Gea, J. (2016) · Chronic Respiratory Disease · doi:10.1177/1479972316642366 · Cited by 87
Self-citationPuig-Vilanova, E., Martínez-Llorens, J., Ausin, P., Roca, J., Gea, J., & Barreiro, E. (2015) · Clinical Science · doi:10.1042/cs20140428 · Cited by 84
Self-citationCardim, A. B., Marinho, P. E., Nascimento, J. F., Fuzari, H. K., & Dornelas de Andrade, A. (2016) · Respiratory Care · doi:10.4187/respcare.04763 · Cited by 32
Metadata
- Authors
- Gea, J., Agustí, A., & Roca, J.
- Venue
- Journal of Applied Physiology
- Publisher
- American Physiological Society
- Published
- 2013-05-01
- Volume
- 114
- Issue
- 9
- Pages
- 1222-1234
- ISSN
- 0161-7567 (ISSN-L)
- 8750-7587
- 1522-1601
- OpenAlex
- W2061769383
- Cited by
- 242
- References
- 32
- FWCI
- 13.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.